 Myomo NYSEAMERICAN: MYO has recently received a number of price target changes and ratings updates: 8192020 Myomo was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders ... 